Ledger.Open graph →
SEC Form D · Amendment · filed July 8, 2014

Remiges BioPharma Fund, LP

Offering
$150.0M
Sold
$70.0M
Exemption
Rule 506(b)
Industry
Pooled Investment Fund
Location
SCARSDALE, NY
Type
Pooled fund

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Walter Olesiak · SCARSDALE, NYExec · DirectorTaro Inaba · TOKYO, M0DirectorRemiges Biopharma Fund Gp, Inc · SCARSDALE, NYExecRemer Y. Brinson Iii · ATLANTA, GAExec · DirectorArchie L. Bransford Jr · ATLANTA, GADirectorRemiges Biopharma Fund Gp, Inc · SCARSDALE, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗